000 01310 a2200313 4500
005 20250517112054.0
264 0 _c20180323
008 201803s 0 0 eng d
022 _a2055-6845
024 7 _a10.1093/ehjcvp/pvw009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _ade Leeuw, Anne E
245 0 0 _aSodium-glucose cotransporter 2 inhibition: cardioprotection by treating diabetes-a translational viewpoint explaining its potential salutary effects.
_h[electronic resource]
260 _bEuropean heart journal. Cardiovascular pharmacotherapy
_c10 2016
300 _a244-55 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aBlood Glucose
_xmetabolism
650 0 4 _aCardiotonic Agents
_xpharmacology
650 0 4 _aDiabetes Mellitus
_xdrug therapy
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xpharmacology
650 0 4 _aSodium-Glucose Transporter 2
650 0 4 _aSodium-Glucose Transporter 2 Inhibitors
700 1 _ade Boer, Rudolf A
773 0 _tEuropean heart journal. Cardiovascular pharmacotherapy
_gvol. 2
_gno. 4
_gp. 244-55
856 4 0 _uhttps://doi.org/10.1093/ehjcvp/pvw009
_zAvailable from publisher's website
999 _c26336409
_d26336409